“Ozempic face” is the hollow, deflated, older look a face can take on after losing a lot of weight quickly. It is not a side effect the drug has on your face. It is facial fat going the same way as fat everywhere else, faster than skin and soft tissue can adjust. Plastic surgeons say the same thing in print: a 2026 review concluded the changes “more plausibly reflect rapid or substantial weight loss than a proven drug-specific facial effect,”2 and a surgeon interviewed by the American Society of Plastic Surgeons called it “a lay term describing facial deflation after rapid weight loss.”4
That distinction decides what you can do about it, and this page goes through all of it: what the one imaging study measured, who is more likely to notice it, what the sources recommend to lower the odds, what fixing it costs, and whether it comes back on its own.
What is Ozempic face?
It is a popular name, not a diagnosis. A 2025 systematic review in the Aesthetic Society's open journal says the term was coined “to describe the exaggerated volume loss from semaglutide therapy, resulting in advanced facial aging.” The same review found that searches for the term rose alongside searches for “face filler” and “plastic surgeons.”5 That tells you who has the strongest interest in the phrase, and it is worth keeping in mind when you read the pages that rank for it.
What people actually describe falls into a few recognisable changes. A 2026 study that built a questionnaire for GLP-1 users, tested on 632 people, lists them in plain words: “sunken cheeks, hollow eyes, saggy skin and an aged appearance.”6 In more detail:
- Flatter, hollower cheeks. The midface loses the curve under the cheekbone; this is where the CT study measured its losses.3
- Hollow eyes. The area around the eye loses padding and looks sunken.6
- Looser skin along the jaw and neck. Surgeons describe volume loss “often accompanied by soft tissue descent and laxity,” which can show as jowls.4
- Lines that read deeper. With less filling them from underneath, the folds from nose to mouth and the transitions between areas of the face look more pronounced.8
None of these is new. They are the ordinary signs of facial aging. What is different is the speed. As one ASPS surgeon put it: “Instead of gradual volume loss over years, patients may see noticeable hollowing or sagging over a much shorter period of time.”4
What the evidence actually shows
For a phrase searched this often, the hard data is thin. Most of the literature is reviews, surveys and case reports. There is one study that measured faces directly, and it is worth knowing in detail.
The CT study: about 7% of midface volume per 10 kg
Facial plastic surgeons at Vanderbilt went through their hospital records for patients who had a GLP-1 prescription and also happened to have head or neck CT or MRI scans both before and after starting it. Twenty patients qualified. Their median age was 54. On average they had been on the medicine for 321 days and had lost 11.0 kg.3
The researchers measured the volume of the midface on each scan. Here is what they reported:
The median percent decrease in total midfacial volume was 9.0% (IQR 3%-14%). Superficial volume decreased by 11.0% (IQR 5%-15%), and deep volume decreased by 7.0% (IQR -20% to 15%).
Their conclusion was that patients “on average can expect a loss of 7% of midfacial volume/10 kg of total weight loss, primarily in superficial fat pads.” The authors call it one of the first quantitative assessments of the phenomenon, and they are right that nobody had measured it before.3
Three things to take from it. First, the loss tracked the amount of weight lost: more kilograms, more facial volume gone. Second, it sat mostly in the superficial fat, the layer just under the skin, which is the layer that gives a face its soft, full contour. A 2026 dermatologic surgery review reads the anatomy the same way, describing midface loss that “seems to occur mainly in superficial fat compartments, contributing to contour flattening and more pronounced transition lines.”8 Third, the spread was wide: the middle half of patients lost anywhere from 3% to 14% of midface volume.
The limits matter. Twenty patients, one hospital, scans taken for other medical reasons, no comparison group losing the same weight without a GLP-1. It is a first measurement, not a final answer. It does not show that the drug does anything to the face beyond the weight it takes off.
The reviews: same picture, more words
A 2026 systematic review of 40 studies on GLP-1 medicines and skin quality reported “facial volume loss (‘Ozempic face’), dermal thinning, loss of collagen and elastin fibers, and decreased skin elasticity.”9 The 2025 plastic surgery systematic review covered 23 articles and flagged its own weakness: its conclusions were “limited by study biases.”5 Both are summaries of mostly small and observational work.
The surveys show demand rather than biology. In a 2026 survey of 406 clinicians who treat cosmetic patients, respondents reported a 137% average rise in patients on GLP-1 medicines from 2023 to 2024, and named midface volume loss and skin laxity of the face and neck among the changes most affected.11 Two of that paper's authors work for Allergan Aesthetics, which sells hyaluronic acid filler, so read its treatment preferences with that in mind.
Is it a side effect of Ozempic?
No. Facial volume loss is not listed as an adverse reaction in the semaglutide prescribing information. The reactions the label does list are overwhelmingly gastrointestinal. Its own summary, from the boxed warning to the most common reactions:1
WARNING: RISK OF THYROID C-CELL TUMORS
Most common adverse reactions (incidence ≥5%) in adults or pediatric patients aged 12 years and older are: nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss.
The surgeons who treat it agree with the label. One of the two ASPS members interviewed in July 2026 said the face can deflate faster than expected when weight comes off quickly, “whether through medication, surgery or lifestyle changes.”4 The route does not matter; the speed and the amount do. GLP-1 medicines are simply the most effective way most people have had to lose that much weight, so the name stuck to them.
If you want the full label, read the manufacturer's prescribing information, and take medical questions to whoever wrote your prescription. We track prices. We do not practise medicine, and a page that ranks for a search term is not a clinician.
What changes and when
There is no week-by-week study of faces on GLP-1 medicines. What exists is weight data from the big trials and the one CT study that links kilograms lost to facial volume. Put together, they give a rough timeline. The facial column for the trial rows is our arithmetic on the Vanderbilt figure of about 7% per 10 kg, which came from 20 people, so treat it as a scale, not a forecast.
| Stage | What the studies measured | What it means for the face |
|---|---|---|
| Early months, while the dose is still being raised | No facial imaging published for this stage. Weight loss builds gradually toward the trial averages below. | No facial data. On the CT study's scale the change grows with kilograms lost, so it is smallest while few have gone. |
| About 10 to 11 months on a GLP-1 | Vanderbilt cohort: average 321 days on treatment, 11.0 kg lost, median 9.0% less midface volume, 11.0% less superficial fat volume.3 | The only point at which facial volume has actually been measured. |
| 68 weeks on semaglutide 2.4 mg | STEP 1: mean weight change of -14.9% (-15.3 kg) against -2.4% on placebo.12 | At about 7% per 10 kg, 15 kg is on the order of a tenth of midface volume. Our arithmetic, not a measurement. |
| Weight steady on a maintenance dose | No study has imaged faces through a stable plateau. | Surgeons treat this as the stage to plan any correction, because the face has stopped changing (see “when to treat” below).4 |
| A year after stopping | STEP 1 extension: people regained 11.6 of the 17.3 percentage points they had lost by week 120, about two-thirds.14 | No imaging study has followed faces through regain. Whether fat returns to the face in the same places is not known. |
The pattern to notice: the face follows the scale, not the calendar or the brand. The more weight that comes off, the more the face changes, and the trial averages for semaglutide sit well into the range where the CT study found measurable loss.
What it looks like
Most of what ranks for this search is a cropped before-and-after with no name attached, which tells you nothing about who the person was, how much they lost or how long it took. This is the same subject from a named clinician, on camera, so you can judge the source as well as the pictures.
Who is more likely to notice it
Not everyone on a GLP-1 gets a face they dislike. The published risk factors are consistent across sources, and none of them is the brand on the pen.
| Factor | What the source found | Source |
|---|---|---|
| How much weight you lose | Superficial midface volume loss correlated with kilograms lost; about 7% of midface volume per 10 kg. | Vanderbilt CT study3 |
| How fast you lose it | Rapid weight loss listed among risk factors for worse skin outcomes. | Skin quality systematic review9 |
| Age | “Advanced age” listed as a risk factor. In a study of 186 pairs of identical twins, a higher BMI made a face look older before 40 but younger after 40. | Systematic review9; twins study15 |
| A long history of obesity | “Prolonged obesity history” listed as a risk factor. | Systematic review9 |
| Low protein and poor hydration | Both listed among risk factors for more severe skin outcomes. | Systematic review9 |
| Smoking and sun | The longer twins had smoked, the older they looked; more sun exposure made a face look older, more so with age. | Twins study15 |
The twins finding is the one most people find surprising. One reading of it: past 40, some facial fat is doing the work of making a face look younger, so the same loss that makes a 30-year-old look leaner can make a 55-year-old look older. For context, the Vanderbilt cohort's median age was 54.315
How to lower the odds: what the sources recommend
Nothing below is advice from us. These are the measures the reviews and the nutrition advisory put forward, quoted so you can take them to the person who prescribes your medicine. The honest caveat first: no trial has tested whether any of them protects the face specifically. They are recommended for skin quality, muscle and overall results, and the face is one place those show.
1. The rate of loss
The 40-study skin review recommends “gradual weight loss, nutritional optimization, hydration, and early dermatologic intervention.”9 Rate is set by the dose, by how quickly it is raised along the dose ladder, and by how much you eat while it works. All three are prescriber decisions. Asking whether a slower climb or a lower maintenance dose fits your goal is a reasonable question to bring. The joint nutrition advisory from four US obesity and nutrition societies also says diet plans should be adjusted “based on the rate of weight reduction.”7
2. Protein
Appetite drops on a GLP-1, and protein is often what falls with it. The joint advisory notes that the general recommended allowance for adults is 0.8 g per kg per day, and that “higher targets, such as 1.2–1.6 g/kg/day, have also been proposed during active weight reduction.” It adds that for people with obesity it is not settled which body weight those targets should be calculated from.7 Your prescriber or a dietitian is the right person to turn that into a number for you.
3. Strength training
The same advisory is blunt that food alone is not enough: “increased protein intake alone is likely inadequate to support the preservation of muscle mass in the absence of structured resistance/strength training.” Its recommendation is “regular strength training at least three times weekly plus at least 150 min of moderate‐intensity aerobic exercise weekly to preserve muscle and bone mass.”7 It cites modelling in which muscle makes up 10% to 15% of the weight women lose and 20% to 25% of the weight men lose when there is no structured strength training. Muscle is not facial fat, so lifting will not refill a cheek. What it does is keep the weight you lose weighted toward fat, and support how the rest of you looks at the end.
4. Sun and smoking
The twins study found both made faces look older, and sun exposure mattered more with age.15 Neither has anything to do with GLP-1 medicines, and both are in your hands.
5. Planning early
Some surgeons now argue for planning ahead rather than correcting later. A 2026 paper proposed a risk model and a four-phase prevention plan matched to weight-loss stages, and it labels itself plainly as “a hypothesis-generating model” that still needs studies to validate it.17 That is where the evidence for prevention is: sensible ideas, not trial results.
The lever nobody prices: staying on
This part is ours, and it is the part almost no page about Ozempic face mentions.
The worst pattern for how a face ends up is not steady loss. It is losing, stopping, regaining and losing again, which asks skin to keep fitting a changing shape. Stopping is common, and so is regain: in the STEP 1 extension, people who came off semaglutide had regained about two-thirds of what they lost within a year.14 Price is part of why people stop. The joint nutrition advisory lists “low long‐term adherence with subsequent weight regain” and “high costs” among the main challenges of GLP-1 treatment.7
On our board today, semaglutide programs run from $41 a month to $299, checked on each seller's own page. A program you can still afford in month twelve is a different proposition from one you drop in month four, and that spread is wide enough to decide which of those you sign up for.
Treatment options and what they cost
Correction is cosmetic, not pharmacological, and it is done by dermatologists and plastic surgeons. Here is what is offered, how it works, and the published cost where one exists. Costs below are national averages from the American Society of Plastic Surgeons; your price depends on the practitioner, the city and how much product your face needs.
| Option | How it works | Published average cost | How long it lasts |
|---|---|---|---|
| Hyaluronic acid filler (Juvederm, Restylane and similar) | A gel injected to replace volume directly. Described by an ASPS surgeon as “quick, relatively low-commitment and reversible.”4 | $715 (ASPS average)10 | Temporary; absorbed over time, so it is repeated. How long depends on the product and the area.16 |
| Collagen stimulators (Sculptra, Radiesse) | Injected to prompt your own collagen. Results build slowly. | $901 (ASPS average for non-hyaluronic acid fillers)10 | For polylactic acid, ASPS says results appear “gradually over a period of a few months,” usually after about three monthly treatments.13 |
| Fat grafting (fat transfer) | Your own fat, moved from another part of the body into the face.4 | No national average on ASPS's patient pages; priced at consultation as a minor surgical procedure | The fat that survives stays, but it grows and shrinks with your weight.4 |
| Facelift | Surgery to lift and tighten skin and deeper tissue. When sagging is significant, ASPS surgeons combine it with volume restoration.4 | $11,395 surgeon's fee (ASPS average), not counting anesthesia or facility costs19 | Does not replace lost volume on its own, which is why it is paired with filler or fat. |
Health insurance does not cover dermal fillers.10 ASPS does not say how many syringes or sessions its averages cover, and a face that has lost volume in several areas may need more than one, so read $715 as an average fee, not a quote for a whole face.
Fillers
Hyaluronic acid fillers are the usual first step, and in the clinician survey they were rated the best option for facial concerns for an average of 47% of patients (remember the Allergan authorship).11 The FDA notes two things worth knowing before you book: because some fillers are absorbed, “patients may need to repeat the procedure after some time to maintain the desired effect,” and “any dermal filler can cause temporary side effects, permanent side effects, or both.”16 Ask who is injecting, what their training is, and what happens if something goes wrong.
Fat grafting
Fat grafting uses your own tissue, which is its appeal. Not all of it survives the move. One ASPS surgeon put long-term survival at “about 65 to 70 percent”; a 2026 review of ultrasound-measured outcomes found retention fell over the first three to six months and then settled at roughly 50% to 70% at one year.418 One open question is specific to GLP-1 users: a 2026 scoping review found that “no clinical or preclinical studies have directly examined fat graft outcomes in patients receiving incretin-based therapies,” and its suggestions for managing the medicine around surgery are, in its own words, hypothesis-generating.20 If you are still on a GLP-1, ask the surgeon how they plan for that.
Surgery
A facelift tightens; it does not refill. When volume loss comes with real sagging, one ASPS surgeon said he commonly combines volume restoration “with a facelift and neck lift.”4 The average surgeon's fee is $11,395, and that figure leaves out anesthesia, the operating room and other related expenses.19
When to treat: during weight loss or after?
The surgeons interviewed by ASPS were consistent: wait. One said, “In most cases, however, I prefer to wait until weight has stabilized or the patient is close to their target weight,” because treating early risks under-correction, over-correction or extra procedures as the face keeps changing. The other pointed out that grafted fat “still behaves like fat anywhere else in the body”: if you gain weight it can enlarge, and if you lose weight it can shrink.4
That makes the plan for your medicine part of the plan for your face. If you expect to stay on a maintenance dose, your weight and your face are more likely to hold still. If you expect to stop, a surgeon will want to know, because regain changes the result.
Does Ozempic face go away?
Partly, and not in a way most people want. Facial fullness follows body fat, so if the weight comes back, some of the fullness tends to come back too. No imaging study has followed faces through regain, so how much returns, and where, is unknown.
Skin is the slower half. The skin review describes dermal thinning, loss of collagen and elastin fibers, and decreased elasticity after GLP-1 weight loss.9 Skin that has lost elasticity may not tighten back fully once weight is steady, and older skin has less to give. So the honest answer is: volume can be replaced, by regain or by treatment; laxity is harder to undo without procedures.
What does not reverse it: we found no clinical evidence that any supplement, cream or facial exercise routine restores lost facial fat volume. Pages promising one are usually selling it.
Be careful whose advice you take. “Ozempic face” is one of the most searched phrases in this market, and a lot of what ranks for it exists to sell a treatment, a product or a clinic visit rather than answer the question.
Ozempic face vs Ozempic butt and body
The same weight loss shows everywhere. The clinician survey named loose or sagging body skin alongside midface loss as the changes most affected.11 Ozempic butt is the name for the version you see from behind: volume loss and looser skin over the buttocks. It has the same causes and the same two levers, which we cover in what Ozempic butt actually is.
The difference is what you can do about it. Facial volume is commonly treated with injections in an office visit. Loose body skin is more often a question for body contouring surgery, and the 2026 aesthetic surgery review reports rising demand for both among GLP-1 users.2 If you are deciding whether to stop or stay on, our guide to what happens to your weight when you stop a GLP-1 covers the regain data in full.
What changed on this page
- 9 October 2026: rebuilt with the Vanderbilt CT study (about 7% of midface volume per 10 kg), the 2025 and 2026 plastic surgery and dermatology reviews, the 2026 clinician survey, a sourced risk-factor table, the joint nutrition advisory's protein and strength-training recommendations, a treatment table with ASPS average fees, the ASPS surgeons' guidance on timing, and a ten-question FAQ. Every source was re-read on this date.
- 8 October 2026: label quote re-checked against the current Wegovy prescribing information.
- 27 August 2026: first published.
The short version
If you are losing a lot of weight, your face will change, whichever route you took. It is not the drug damaging you, and it is not a warning sign. How much shows depends mostly on how much you lose, how fast, and how old your skin is. The parts you can influence are the rate of loss, set with your prescriber; the protein and strength work the nutrition advisory recommends; and picking a program you can still afford in month twelve, so you are not losing, stopping and regaining. If you decide to treat your face, the surgeons' advice is to wait until your weight is steady, and the plastic surgeons' published average for hyaluronic acid filler is $715.
